InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 19.99
+2.08 (11.61%)
At close: Mar 27, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 11.56 billion as of March 27, 2026. Its market cap has increased by 21.78% in one year.
Market Cap
11.56B
Enterprise Value
10.05B
Revenue
37.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.99
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 11.56B, an increase of 31.50%. That is a compound annual growth rate of 7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.56B | -26.62% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| Chengdu Olymvax Biopharmaceuticals | 12.07B |
| Beijing Hotgen Biotech | 11.74B |
| Chengdu Easton Biopharmaceuticals | 11.57B |